Pre Transplantation Melanoma

Pre Transplantation Melanoma : Retrospective and Prospective Multicenter Observational Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04217382

Acronym

MPG

Enrollment

Registered

2020-01-03

Start date

2020-02-27

Completion date

2020-08-31

Last updated

2021-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Melanoma

Brief summary

Melanoma incidence is increase in global population and number of transplantation also. However immunosuppressor increase recurrence risk of melanoma. There are more and more cases of eligible patients to transplant with an antecedent of melanoma. There is no guideline yet. Main objective is survival time without melanoma recurrence in this population to do guideline of time limit or not between melanoma and transplantation by stage.

Interventions

OTHERpatient with melanoma pre transplantation

survival time without melanoma recurrence

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* patient with an antecedent of melanoma before transplantation * Not opposite to participate

Exclusion criteria

* Under the age of 18 * patient under Guardianship * patient not affiliated with a health system

Design outcomes

Primary

Measure	Time frame	Description
survival time without melanoma recurrence	at enrollment	Delay in recurrence-free survival since diagnosis and since transplantation

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026